Life-course trajectories of cannabis use: a latent class analysis of a New Zealand birth cohort
- PMID: 31503369
- DOI: 10.1111/add.14814
Life-course trajectories of cannabis use: a latent class analysis of a New Zealand birth cohort
Abstract
Background and aims: Little is known about how cannabis use over the life-course relates to harms in adulthood. The present study aimed to identify trajectories of cannabis use from adolescence to adulthood and examine both the predictors of these trajectories and adverse adult outcomes associated with those trajectories.
Design: A latent trajectory analysis of a longitudinal birth cohort (from birth to age 35 years).
Setting and participants: General community sample (n = 1065) from New Zealand.
Measurement: Annual frequency of cannabis use (ages 15-35 years); childhood family and individual characteristics (birth to age 16 years); measures of adult outcomes (substance use disorders, ages 30-35 years; mental health disorders, ages 30-35 years; socio-economic outcomes at age 35 years; social/family outcomes at age 35 years).
Findings: A six-class solution was the best fit to the data. Individuals assigned to trajectories with higher levels of cannabis use were more likely to have experienced adverse childhood family and individual circumstances. Membership of trajectories with higher levels of use was associated with increased risk of adverse outcomes at ages 30-35 years. Adjustment of these associations for the childhood family and individual predictors largely did not reduce the magnitude of the associations.
Conclusions: In New Zealand, long-term frequent cannabis use, or transition to such use, appears to be robustly associated with diverse harms in adulthood.
Keywords: Cannabis; birth cohort; latent trajectory analysis; longitudinal studies; mental health; psychosocial outcomes.
© 2019 Society for the Study of Addiction.
Similar articles
-
Relation between age of first drinking and mental health and alcohol and drug disorders in adulthood: evidence from a 35-year cohort study.Addiction. 2016 Apr;111(4):637-44. doi: 10.1111/add.13230. Epub 2016 Jan 8. Addiction. 2016. PMID: 26566814
-
Developmental trajectories of adolescent cannabis use and their relationship to young adult social and behavioural adjustment: A longitudinal study of Australian youth.Addict Behav. 2016 Feb;53:11-8. doi: 10.1016/j.addbeh.2015.09.008. Epub 2015 Sep 21. Addict Behav. 2016. PMID: 26414206
-
Cannabis use and later life outcomes.Addiction. 2008 Jun;103(6):969-76; discussion 977-8. doi: 10.1111/j.1360-0443.2008.02221.x. Addiction. 2008. PMID: 18482420
-
Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study.Soc Psychiatry Psychiatr Epidemiol. 2015 Sep;50(9):1317-26. doi: 10.1007/s00127-015-1070-x. Epub 2015 May 26. Soc Psychiatry Psychiatr Epidemiol. 2015. PMID: 26006253 Review.
-
[Cohort studies in child and adolescent psychiatry].Nervenarzt. 2021 Mar;92(3):208-218. doi: 10.1007/s00115-020-01018-4. Epub 2020 Oct 28. Nervenarzt. 2021. PMID: 33112964 Free PMC article. Review. German.
Cited by
-
First-Year Trajectories of Medical Cannabis Use Among Adults Taking Opioids for Chronic Pain: An Observational Cohort Study.Pain Med. 2021 Dec 11;22(12):3080-3088. doi: 10.1093/pm/pnab257. Pain Med. 2021. PMID: 34411246 Free PMC article.
-
Early, Chronic, and Acute Cannabis Exposure and Their Relationship With Cognitive and Behavioral Harms.Front Psychiatry. 2021 Aug 9;12:643556. doi: 10.3389/fpsyt.2021.643556. eCollection 2021. Front Psychiatry. 2021. PMID: 34434125 Free PMC article.
-
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations.Drug Alcohol Rev. 2020 Jul;39(5):555-567. doi: 10.1111/dar.13087. Epub 2020 May 20. Drug Alcohol Rev. 2020. PMID: 32436274 Free PMC article. Review.
-
Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review.Front Psychiatry. 2022 Oct 10;13:973988. doi: 10.3389/fpsyt.2022.973988. eCollection 2022. Front Psychiatry. 2022. PMID: 36299544 Free PMC article.
-
Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis.Front Public Health. 2024 May 22;12:1356988. doi: 10.3389/fpubh.2024.1356988. eCollection 2024. Front Public Health. 2024. PMID: 38841675 Free PMC article.
References
-
- Degenhardt L., Ferrari A. J., Hall W. D. Chapter 10. The global epidemiology and disease burden of cannabis use and dependence. In: Preedy V. R., editor. Handbook of Cannabis and Related Pathologies. San Diego, CA: Academic Press; 2017, pp. 89-100.
-
- Degenhardt L., Whiteford H., Hall W. D. The global burden of disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug Alcohol Rev 2014; 33: 4-12.
-
- Newton-Howes G. Cannabis as medicine. BMJ 2017; 357: 2130.
-
- Hall W., Lynskey M. Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction 2016; 111: 1764-1773.
-
- Patton G. C., Coffey C., Lynskey M. T., Reid S., Hemphill S., Carlin J. B., et al. Trajectories of adolescent alcohol and cannabis use into young adulthood. Addiction 2007; 102: 607-615.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical